CytoDyn Inc. (CYDY: OTCQB) | CytoDyn to Initiate 8
Post# of 35796
(Total Views: 28)
Posted On: 02/19/2019 6:45:02 AM
CytoDyn Inc. (CYDY: OTCQB) | CytoDyn to Initiate 8 Pre-Clinical Animal Studies with Leronlimab (PRO 140) for Melanoma, Pancreatic, Breast, Prostate, Colon, Lung, Liver, and Stomach Cancer at an Estimated Cost of $1.5 million, which Could Lead to 8 Phase 2 Clinical Studies
(0)
(0)Scroll down for more posts ▼